Kimberly-Clark Corporation
24
1
1
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
2 terminated/withdrawn out of 24 trials
91.3%
+4.8% vs industry average
8%
2 trials in Phase 3/4
29%
6 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Tampon Safety-in-Use Study
Role: lead
Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)
Role: lead
Very Low Birth Weight Preterm Infant Bundled Care in the NICU
Role: collaborator
Tampon Design Validation Study
Role: lead
Cooled Radiofrequency Ablation vs. Thermal Radiofrequency Ablation
Role: collaborator
Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
Role: collaborator
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
Role: collaborator
Continuous Local Anesthetic Infusion Following Hernia Repair
Role: collaborator
BM Characterization Pilot
Role: lead
Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation
Role: lead
Project SHARE (motherS Have All the Right microbEs)
Role: lead
Micro-Technique Sampling
Role: lead
Infant Fecal Insult Study
Role: lead
Infant Microbiome in Diaper Rash
Role: lead
BM Collection From NICU Infants for Composition
Role: lead
Rudolph: Nasal Microbiota With Red and Sore Nose
Role: lead
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
Role: lead
Nasal Swab Study to Explore the Nasal Microbia
Role: lead
Ex Vivo High-Throughput Assay for Vaginal Community Post-menopausal Women
Role: lead
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
Role: collaborator